Biology Reference
In-Depth Information
26. Barcellos-Hoff MH, Ravani SA: Irradiated mammary gland stroma promotes
the expression of tumorigenic potential by unirradiated epithelial cells. Cancer
Res 2000, 60:1254-1260.
27. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C: The stroma as a
crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004, 117:1495-
1502.
28. Schedin P, Mitrenga T, McDaniel S, Kaeck KM: Mammary ECM composition
and function are altered by reproductive state. Mol Carcinog 2004, 41:207-
220.
29. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S: Pre-
vention of mammary carcinogenesis by short-term estrogen and progestin treat-
ments. Breast Cancer Res 2004, 6:R31-R37.
30. Swanson SM, Guzman RC, Collins G, Tafoya P, Thordarson G, Talamantes F,
Nandi S: Refractoriness to mammary carcinogenesis in the parous mouse is
reversible by hormonal stimulation induced by pituitary isografts. Cancer Lett
1995, 90:171-181.
31. Thordarson G, Van Horn K, Guzman RC, Nandi S, Talamantes F: Parous rats
regain high susceptibility to chemically induced mammary cancer after treat-
ment with various mammotropic hormones. Carcinogenesis 2001, 22:1027-
1033.
32. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM: Persistent changes in
gene expression induced by estrogen and progesterone in the rat mammary
gland. Mol Endocrinol 2001, 15:1993-2009.
33. Ginger MR, Rosen JM: Pregnancy-induced changes in cell-fate in the mam-
mary gland. Breast Cancer Res 2003, 5:192-197.
34. hordarson G, Semaan S, Low C, Ochoa D, Leong H, Rajkumar L, Guzman
RC, Nandi S, Talamantes F: Mammary tumorigenesis in growth hormone defi-
cient spontaneous dwarf rats; effects of hormonal treatments. Breast Cancer Res
Treat 2004, 87:277-290.
35. Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R, Nandi
S, Talamantes F: Insulin-like growth factor (IGF)-I obliterates the pregnancy-
associated protection against mammary carcinogenesis in rats: evidence that
IGF-I enhances cancer progression through estrogen receptor-
α
activation via
the mitogen-activated protein kinase pathway. Breast Cancer Res 2004, 6:R423-
R436. 36. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M,
Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, et al.: Influence
of estrogen plus progestin on breast cancer and mammography in healthy post-
menopausal women: the Women's Health Initiative Randomized Trial. JAMA
2003, 289:3243-3253.
Search WWH ::
Custom Search